Concentrations of Chloroquine and Malaria Parasites in Blood in Nigerian Children
Open Access
- 1 April 2000
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (4), 835-839
- https://doi.org/10.1128/aac.44.4.835-839.2000
Abstract
Consumption of chloroquine (CQ) and subtherapeutic drug levels in blood are considered to be widespread in areas where malaria is endemic. A cross-sectional study was performed with 405 Nigerian children to assess factors associated with the presence of CQ in blood and to examine correlations of drug levels with malaria parasite species and densities. Infections with Plasmodium species and parasite densities were determined by microscopy and PCR assays. Whole-blood CQ concentrations were measured by high-performance liquid chromatography. Plasmodium falciparum , P. malariae , and P. ovale were observed in 80, 16, and 9% of the children, respectively, and CQ was detected in 52% of the children. CQ concentrations were >17 and P. falciparum infection and parasite densities decreased. However, at concentrations corresponding to those usually attained during regular prophylaxis (≥500 nmol/liter), 62% of children were still harboring P. falciparum parasites. In contrast, no infection with P. malariae and only one infection with P. ovale were observed in children with CQ concentrations of ≥100 nmol/liter. These data show the high prevalence of subcurative CQ concentrations in Nigerian children and confirm the considerable degree of CQ resistance in that country. Subtherapeutic drug levels are likely to further promote CQ resistance and may impair the development and maintenance of premunition in areas where malaria is endemic.Keywords
This publication has 27 references indexed in Scilit:
- Complexity ofPlasmodium falciparumInfections Is Consistent over Time and Protects against Clinical Disease in Tanzanian ChildrenThe Journal of Infectious Diseases, 1999
- Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infantsThe Lancet, 1997
- High incidence of malaria in α-thalassaemic childrenNature, 1996
- Validity of mother's history regarding antimalarial drug use in Malawian children under five years oldTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis.British Journal of Clinical Pharmacology, 1995
- High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reactionMolecular and Biochemical Parasitology, 1993
- The development and spread of drug-resistant malariaParasitology Today, 1991
- Drug use before hospital admission in ZimbabweEuropean Journal of Clinical Pharmacology, 1988
- Chloroquine excretion following malaria prophylaxis.British Journal of Clinical Pharmacology, 1987
- Sensitive method for the determination of chloroquine and its metabolite desethyl-chloroquine in human plasma and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980